Market Overview - The market is experiencing continued sector rotation, with the S&P 500 advanced decline line showing a balanced 50/50 performance, indicating potential volatility ahead [2][3] - The S&P 500 is down over 0.5%, primarily affected by the technology sector, suggesting a shift of investments between sectors like financials and energy [3] Broadcom (AVGO) - Broadcom shares are under slight pressure, down about 0.25%, despite reporting record revenue for Q3 [4] - A bearish outlook is presented due to concerns over AI spending and profitability, with significant investments in AI and server farms raising questions about future upside potential [5][7] - A bearish trade strategy involves buying 310 puts and selling 300 puts, creating a $10 wide put spread for a $263 debit [7] Eli Lilly (LLY) - Eli Lilly is constructing a $6.5 billion plant for a new obesity weight loss pill, but the stock is down nearly 20% year-to-date and flat over the last year [15] - A bearish position is taken based on technical analysis, with expectations for the stock to drop back to the $700 range [19] - The trade involves buying a 242.5 put and selling a 240 put, creating a $2.50 wide put spread for a $90 debit [19] Goldman Sachs (GS) - Goldman Sachs has seen a 40% increase year-to-date, with a 10% rise in the last 12 trading sessions, attributed to a slowing economic backdrop [27][28] - A bearish sentiment is expressed, with concerns that the stock's performance does not reflect a genuine improvement in business fundamentals [30] - A bearish trade strategy includes buying 765 puts and selling 755 puts, creating a $10 wide put spread for a $2.70 debit [30]

Welcome back to Money Movers. Take a look at Novo today. Down double digits on pace for the worst day since 87 as the company cuts slashes really its fullear guidance.Novo saying that it now expects weaker growth expectations in the second half for GLP1 drugs WGOmpic. Company also announces the appointment of its incoming CEO Mike Dotstar effective August 7th. Joining us now to break down the move is Missouo healthcare equity strategist Jared Holtz.Jared, who writes, "Today, we believe analysts will start t ...